Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02065869
Title Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

hematologic cancer

Therapies

Rivogenlecleucel

Rimiducid

Age Groups: adult | child
Covered Countries ITA


No variant requirements are available.